FTSE All-Share
|
4 986,34
|
-9,01
|
-0,18 %
|
Analysen zu FTSE All-Share-Werten
| 13.02.24 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 13.02.24 | BAT Neutral | UBS AG | |
| 13.02.24 | Glencore Outperform | RBC Capital Markets | |
| 13.02.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 12.02.24 | AstraZeneca Halten | DZ BANK | |
| 12.02.24 | Unilever Market-Perform | Bernstein Research | |
| 12.02.24 | Diageo Sell | Deutsche Bank AG | |
| 12.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 12.02.24 | BP Outperform | RBC Capital Markets | |
| 12.02.24 | BAT Neutral | Goldman Sachs Group Inc. | |
| 12.02.24 | AstraZeneca Overweight | Barclays Capital | |
| 09.02.24 | GSK Buy | UBS AG | |
| 09.02.24 | AstraZeneca Sell | UBS AG | |
| 09.02.24 | Unilever Sell | UBS AG | |
| 09.02.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 09.02.24 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.02.24 | Unilever Overweight | Barclays Capital | |
| 09.02.24 | Unilever Underperform | Jefferies & Company Inc. | |
| 09.02.24 | GSK Buy | Jefferies & Company Inc. | |
| 09.02.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 08.02.24 | Diageo Underperform | RBC Capital Markets | |
| 08.02.24 | GSK Buy | Deutsche Bank AG | |
| 08.02.24 | AstraZeneca Sell | UBS AG | |
| 08.02.24 | BAT Neutral | UBS AG | |
| 08.02.24 | Unilever Market-Perform | Bernstein Research | |
| 08.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 08.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 08.02.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 08.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 08.02.24 | Unilever Sector Perform | RBC Capital Markets | |
| 07.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 07.02.24 | BP Buy | UBS AG | |
| 07.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 07.02.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 06.02.24 | BP Overweight | Barclays Capital | |
| 06.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 06.02.24 | BP Outperform | RBC Capital Markets | |
| 06.02.24 | BP Hold | Jefferies & Company Inc. | |
| 06.02.24 | GSK Buy | UBS AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.